Preliminary results of an intravitreal dexamethasone implant (Ozurdex ® ) in patients with persistent diabetic macular edema

Elena Pacella,Anna Rita Vestri,Roberto Muscella,Maria Rosaria Carbotti,Massimo Castellucci,Luigi Coi,Paolo Turchetti,Fernanda Pacella

Preliminary results of an intravitreal dexamethasone implant (Ozurdex ® ) in patients with persistent diabetic macular edema

2013

Elena Pacella
Anna Rita Vestri
Roberto Muscella
Maria Rosaria Carbotti
Massimo Castellucci
Luigi Coi
Paolo Turchetti
Fernanda Pacella

Background To evaluate the efficacy and safety of an intravitreal dexamethasone implant (Ozurdex®; Allergan Inc, Irvine, CA, USA) in patients with persistent diabetic macular edema (DME) over a 6-month follow-up period.

Keywords:

Alternative medicine
Surgery
Dexamethasone
Medicine
Macular edema
Implant
diabetic macular edema
Visual acuity
Ophthalmology
Diabetes mellitus
Diabetic retinopathy
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations